GS16-03

Main Content

Donor selection for allogeneic stem cell transplantation: a case-control comparison of children (using post-transplantation cyclophosphamide in GVHD prophylaxis) versus HLA-matched siblings

Study #: GS16-03

Study Status: Published

Presentation(s)

2017, ASH (Oral)

Related donor transplants: Has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?

Citation

Robinson TM, Fuchs EJ, Zhang M-J, St Martin A, Labopin M, Keesler DA, Blaise D, Bashey A, Bourhis J-H, Ciceri F, Ciurea SO, Devine SM, Mohty M, McCurdy SR, Milpied N, McNiece IK, Rocha V, Romee R, Socie G, Yakoub-Agha I, Soiffer RJ, Eapen M, Nagler A.

Blood Advances. 2018, Jun 12: 2(11): 2(11):1180-1186. doi: 10.1182/bloodadvances.2018018291. Epub 2018, May 24. PMCID:PMC5998932.

PubMed

PMID: 29794073

Abstract